AMP Capital Investors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-120,252
| Closed | -$21.2M | – | 1268 |
|
|
2020
Q1 | $21.2M | Buy |
120,252
+10,352
| +9% | +$1.95M | 0.16% | 157 |
|
|
2019
Q4 | $20.9M | Buy |
109,900
+179
| +0.2% | +$32.3K | 0.11% | 210 |
|
|
2019
Q3 | $18.5M | Sell |
109,721
-10,671
| -9% | -$1.74M | 0.1% | 231 |
|
|
2019
Q2 | $20M | Sell |
120,392
-17,368
| -13% | -$2.4M | 0.11% | 211 |
|
|
2019
Q1 | $20.2M | Sell |
137,760
-4,569
| -3% | -$662K | 0.11% | 211 |
|
|
2018
Q4 | $18.9M | Buy |
142,329
+24,205
| +20% | +$3.97M | 0.12% | 196 |
|
|
2018
Q3 | $22.5M | Buy |
118,124
+18,786
| +19% | +$3.45M | 0.12% | 203 |
|
|
2018
Q2 | $16.6M | Buy |
99,338
+8,125
| +9% | +$1.3M | 0.09% | 250 |
|
|
2018
Q1 | $15.1M | Buy |
91,213
+2,085
| +2% | +$350K | 0.09% | 269 |
|
|
2017
Q4 | $14.6M | Sell |
89,128
-4,841
| -5% | -$869K | 0.08% | 283 |
|
|
2017
Q3 | $19.3M | Sell |
93,969
-18,478
| -16% | -$4.3M | 0.11% | 214 |
|
|
2017
Q2 | $27.4M | Sell |
112,447
-19,823
| -15% | -$4.66M | 0.16% | 150 |
|
|
2017
Q1 | $31.7M | Buy |
132,270
+2,270
| +2% | +$529K | 0.19% | 127 |
|
|
2016
Q4 | $26.9M | Sell |
130,000
-10,113
| -7% | -$2.09M | 0.16% | 139 |
|
|
2016
Q3 | $32.3M | Sell |
140,113
-20,665
| -13% | -$5.05M | 0.2% | 115 |
|
|
2016
Q2 | $37.1M | Sell |
160,778
-2,318
| -1% | -$534K | 0.25% | 94 |
|
|
2016
Q1 | $44.8M | Buy |
163,096
+7,588
| +5% | +$2.17M | 0.3% | 78 |
|
|
2015
Q4 | $49M | Sell |
155,508
-680
| -0.4% | -$202K | 0.33% | 72 |
|
|
2015
Q3 | $39.4M | Sell |
156,188
-16,183
| -9% | -$4.97M | 0.29% | 82 |
|
|
2015
Q2 | $51.6M | Buy |
172,371
+9,176
| +6% | +$2.74M | 0.33% | 79 |
|
|
2015
Q1 | $49.7M | Buy |
163,195
+34,853
| +27% | +$9.94M | 0.3% | 84 |
|
|
2014
Q4 | $33.3M | Sell |
128,342
-13,252
| -9% | -$3.31M | 0.2% | 124 |
|
|
2014
Q3 | $34.6M | Buy |
141,594
+41,963
| +42% | +$9.39M | 0.22% | 113 |
|
|
2014
Q2 | $22.2M | Buy |
99,631
+4,918
| +5% | +$1.02M | 0.14% | 187 |
|
|
2014
Q1 | $19.3M | Buy |
94,713
+11,259
| +13% | +$2.23M | 0.13% | 203 |
|
|
2013
Q4 | $13.8M | Buy |
83,454
+40,532
| +94% | +$6.34M | 0.1% | 256 |
|
|
2013
Q3 | $6.19M | Sell |
42,922
-31,847
| -43% | -$4.24M | 0.05% | 430 |
|
|
2013
Q2 | $9.41M | Buy |
+74,769
| New | +$8.47M | 0.07% | 305 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
AMP Capital Investors's AGN Position: Q2 2020 in Review
AMP Capital Investors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 120,252 shares — an estimated $21.2M sold.
AMP Capital Investors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $51.6M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- AMP Capital Investors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- AMP Capital Investors sold 120,252 Allergan plc shares in Q2 2020, an estimated $21.2M.
- AMP Capital Investors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- AMP Capital Investors's Allergan plc position peaked at $51.6M in Q2 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on AMP Capital Investors's 13F filing for Q2 2020, filed 14 Aug 2020.